Avience Biomedicals Ltd

NSE: AVIENCE · Healthcare · 9 announcements

Share price: ₹294.00
Market cap: ₹161.3 Cr
Revenue (annual): ₹52.51 Cr
Net profit (annual): ₹8.75 Cr
P/E (TTM): 18.4×Sector 53.1×
Promoter holding: 64.59%
FII holding: 3.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Annual General Meeting 2 Management Change 1 Financial Results 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

17 Jul 2026 01:56 IST NSE

Board Meeting Outcome

Avience Biomedicals Board Meeting Outcome

Avience Biomedicals approved its audited standalone and consolidated financial results for FY26. The board also noted non-applicability of certain SEBI corporate governance and fund utilization disclosures.

Read the filing ↗